BioAtla (BCAB) Other Accumulated Expenses (2020 - 2026)
BioAtla (BCAB) posted quarterly Other Accumulated Expenses of $941000.0 for Q1 2026, up 4.79% year-over-year from $898000.0 in Q1 2025, and up 7.05% quarter-over-quarter from $879000.0 in Q4 2025.
BioAtla (BCAB) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
BioAtla's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $941000.0 for Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 4.79% year-over-year to $941000.0; the TTM figure through Mar 2026 stood at $941000.0 (up 4.79% YoY), while the FY2025 annual figure was $879000.0, down 15.72% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $941000.0, up from $879000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $1.8 million in Q2 2022, with the low at $509000.0 in Q3 2025.
- The 5-year median for Other Accumulated Expenses is $865000.0 (2023), against an average of $863941.2.
- The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses surged 181.49% in 2022, then sank 50.59% in 2023.
- BioAtla's Other Accumulated Expenses stood at $1.3 million in 2022, then sank by 32.37% to $865000.0 in 2023, then advanced by 20.58% to $1.0 million in 2024, then fell by 15.72% to $879000.0 in 2025, then advanced by 7.05% to $941000.0 in 2026.
- Business Quant data shows BCAB's Other Accumulated Expenses at $941000.0 in Q1 2026, $879000.0 in Q4 2025, and $509000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BioAtla | 5.41 Mn | 5.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 384,000.00 |
| Mar 31, 2026 | 941,000.00 |
| Dec 31, 2025 | 879,000.00 |
| Sep 30, 2025 | 509,000.00 |
| Jun 30, 2025 | 715,000.00 |
| Mar 31, 2025 | 898,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 786,000.00 |
| Jun 30, 2024 | 562,000.00 |
| Mar 31, 2024 | 517,000.00 |
| Dec 31, 2023 | 865,000.00 |
| Sep 30, 2023 | 542,000.00 |
| Jun 30, 2023 | 879,000.00 |
| Mar 31, 2023 | 707,000.00 |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 939,000.00 |
| Jun 30, 2022 | 1.78 Mn |
| Mar 31, 2022 | 847,000.00 |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 551,000.00 |